These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32072692)

  • 1. Late clinical outcomes of lambre versus amplatzer occluders for left atrial appendage closure.
    Schnupp S; Liu XX; Buffle E; Gloekler S; Mohrez Y; Cheikh-Ibrahim M; Allakkis W; Brachmann J; Park JW; Kleinecke C
    J Cardiovasc Electrophysiol; 2020 Apr; 31(4):934-942. PubMed ID: 32072692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term clinical outcomes of Amplatzer cardiac plug versus Amulet occluders for left atrial appendage closure.
    Kleinecke C; Cheikh-Ibrahim M; Schnupp S; Fankhauser M; Nietlispach F; Park JW; Brachmann J; Windecker S; Meier B; Gloekler S
    Catheter Cardiovasc Interv; 2020 Sep; 96(3):E324-E331. PubMed ID: 31631493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early results of first versus second generation Amplatzer occluders for left atrial appendage closure in patients with atrial fibrillation.
    Gloekler S; Shakir S; Doblies J; Khattab AA; Praz F; Guerios Ê; Koermendy D; Stortecky S; Pilgrim T; Buellesfeld L; Wenaweser P; Windecker S; Moschovitis A; Jaguszewski M; Landmesser U; Nietlispach F; Meier B
    Clin Res Cardiol; 2015 Aug; 104(8):656-65. PubMed ID: 25736061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes of Watchman vs. Amplatzer occluders for left atrial appendage closure (WATCH at LAAC).
    Kleinecke C; Yu J; Neef P; Buffle E; de Marchi S; Fuerholz M; Nietlispach F; Valgimigli M; Streit SR; Fankhauser M; Duenninger E; Windecker S; Meier B; Gloekler S
    Europace; 2020 Jun; 22(6):916-923. PubMed ID: 32003774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review on left atrial appendage closure with the LAmbre device in patients with non-valvular atrial fibrillation.
    Ali M; Rigopoulos AG; Mammadov M; Torky A; Auer A; Matiakis M; Abate E; Bakogiannis C; Tzikas S; Bigalke B; Sedding D; Noutsias M
    BMC Cardiovasc Disord; 2020 Feb; 20(1):78. PubMed ID: 32050904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of Early (1-Week) Outcomes Following Left Atrial Appendage Closure With Amplatzer Devices.
    Koskinas KC; Shakir S; Fankhauser M; Nietlispach F; Attinger-Toller A; Moschovitis A; Wenaweser P; Pilgrim T; Stortecky S; Praz F; Räber L; Windecker S; Meier B; Gloekler S
    JACC Cardiovasc Interv; 2016 Jul; 9(13):1374-83. PubMed ID: 27388826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of individual stroke risk on outcome after Amplatzer left atrial appendage closure in patients with atrial fibrillation.
    Häner JD; Fürholz M; Kleinecke C; Galea R; Streit SR; Fankhauser M; Cherni T; Valgimigli M; Windecker S; Meier B; Gloekler S
    Catheter Cardiovasc Interv; 2021 Jun; 97(7):E1002-E1010. PubMed ID: 33022121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of percutaneous left atrial appendage closure using a novel LAmbre occluder in patients with atrial fibrillation: Initial results from a prospective cohort registry study.
    Chen S; Schmidt B; Bordignon S; Bologna F; Nagase T; Tsianakas N; Perrotta L; Chun KRJ
    J Cardiovasc Electrophysiol; 2018 Feb; 29(2):291-297. PubMed ID: 29149516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left atrial appendage occlusion using LAmbre Amulet and Watchman in atrial fibrillation.
    Chen S; Chun KRJ; Bordignon S; Weise FK; Nagase T; Perrotta L; Bologna F; Schmidt B
    J Cardiol; 2019 Apr; 73(4):299-306. PubMed ID: 30583991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left atrial appendage closure versus medical therapy in patients with atrial fibrillation: the APPLY study.
    Gloekler S; Fürholz M; de Marchi S; Kleinecke C; Streit SR; Buffle E; Fankhauser M; Häner JD; Nietlispach F; Galea R; Windecker S; Meier B
    EuroIntervention; 2020 Oct; 16(9):e767-774. PubMed ID: 32583806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amplatzer left atrial appendage occlusion: single center 10-year experience.
    Nietlispach F; Gloekler S; Krause R; Shakir S; Schmid M; Khattab AA; Wenaweser P; Windecker S; Meier B
    Catheter Cardiovasc Interv; 2013 Aug; 82(2):283-9. PubMed ID: 23412815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amplatzer left atrial appendage closure: Single versus combined procedures.
    Kleinecke C; Buffle E; Link J; Häner J; Sedaghat A; Galea R; Streit SR; Windecker S; Meier B; Gloekler S
    Catheter Cardiovasc Interv; 2021 Jun; 97(7):E973-E981. PubMed ID: 32930492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of percutaneous left atrial appendage closure with the Amplatzer cardiac plug in patients with atrial fibrillation and contraindications to anticoagulation.
    Wiebe J; Bertog S; Franke J; Wettstein O; Lehn K; Hofmann I; Vaskelyte L; Sievert H
    Catheter Cardiovasc Interv; 2014 Apr; 83(5):796-802. PubMed ID: 24327462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial experience of percutaneous left atrial appendage closure using the LAmbre device for thromboembolic prevention.
    Reinsch N; Ruprecht U; Buchholz J; Edel C; Kälsch H; Neven K
    J Cardiovasc Med (Hagerstown); 2018 Sep; 19(9):491-496. PubMed ID: 29894355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous Left Atrial Appendage Closure With the LAmbre Device for Stroke Prevention in Atrial Fibrillation: A Prospective, Multicenter Clinical Study.
    Huang H; Liu Y; Xu Y; Wang Z; Li Y; Cao K; Zhang S; Yang Y; Yang X; Huang D; Yu B; Su X; Wu L; Huang C
    JACC Cardiovasc Interv; 2017 Nov; 10(21):2188-2194. PubMed ID: 29122133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new left atrial appendage occluder (Lifetech LAmbre Device) for stroke prevention in atrial fibrillation.
    Lam YY
    Cardiovasc Revasc Med; 2013; 14(3):134-6. PubMed ID: 23773494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Safety and Efficacy in Continued Access Left Atrial Appendage Closure Registries.
    Holmes DR; Reddy VY; Gordon NT; Delurgio D; Doshi SK; Desai AJ; Stone JE; Kar S
    J Am Coll Cardiol; 2019 Dec; 74(23):2878-2889. PubMed ID: 31806131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transseptal puncture versus patent foramen ovale or atrial septal defect access for left atrial appendage closure.
    Kleinecke C; Fuerholz M; Buffle E; de Marchi S; Schnupp S; Brachmann J; Nietlispach F; Fankhauser M; Streit SR; Windecker S; Meier B; Gloekler S
    EuroIntervention; 2020 Jun; 16(2):e173-e180. PubMed ID: 31449043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety of Left Atrial Appendage Closure With WATCHMAN in Japanese Nonvalvular Atrial Fibrillation Patients　- Final 2-Year Follow-up Outcome Data From the SALUTE Trial.
    Aonuma K; Yamasaki H; Nakamura M; Matsumoto T; Takayama M; Ando K; Hirao K; Goya M; Morino Y; Hayashida K; Kusano K; Gomi Y; Main ML; Uchida T; Saito S
    Circ J; 2020 Jul; 84(8):1237-1243. PubMed ID: 32595176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Device-Related Thrombus After Left Atrial Appendage Closure: Incidence, Predictors, and Outcomes.
    Dukkipati SR; Kar S; Holmes DR; Doshi SK; Swarup V; Gibson DN; Maini B; Gordon NT; Main ML; Reddy VY
    Circulation; 2018 Aug; 138(9):874-885. PubMed ID: 29752398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.